POLARIS Project Explores the Code of mRNA Stability
Human Technopole has been awarded a €1.35 million Consolidator Grant from the Fondo Italiano per la Scienza (FIS3) to investigate how cells control the stability of messenger RNAs. The funding will support the POLARIS project, led by the Legnini Group, which aims to uncover the molecular principles governing the synthesis and regulation of poly(A) tails, a key feature that determines how long mRNA molecules survive and function inside cells.
From Integrated Reporting to Student Innovation: Human Technopole at the Social Innovation Campus 2026
The Social Innovation Campus 2026 was a great success, bringing thousands of students to MIND to discuss social innovation, sustainability and the future of work. From 25 to 27 February, young people engaged with organisations, institutions and companies to explore how innovation can generate social impact. Human Technopole contributed to this collective effort through different voices and perspectives.
4 PhD Positions in Data Analytics and Decision Sciences at Human Technopole
Are you passionate about AI, mathematical modelling, or genomics, and eager to work on high-impact research in biomedical science? Human Technopole is excited to offer four fully-funded PhD positions as part of the prestigious PhD Programme in Data Analytics and Decision Sciences of the Politecnico di Milano.
1 PhD Position in the Harschnitz Group within the IGNITION Doctoral Programme
We are pleased to announce that one fully funded PhD position is available in the Harschnitz Group as part of the prestigious IGNITION Doctoral Programme, funded under the Marie Skłodowska-Curie Actions (MSCA).
From RNA to proteins: AIRC supports Human Technopole’s new approaches to cancer research
Lorenzo Calviello and his group of the Human Technopole’s Research Centres for Genomics and Computational Biology have been awarded a five-year My First AIRC Grant by Fondazione AIRC per la Ricerca sul Cancro. The grant provides over €99,000 for 2026, for a total of €500,000, to support a project aimed at identifying cancer-specific proteins that could serve as new immunotherapy targets in colorectal cancer.
Previous page